- Research
- Open access
- Published:
Peripheral blood monocyte status is a predictor for judging occurrence and development on sepsis in older adult population: a case control study
BMC Emergency Medicine volume 23, Article number: 11 (2023)
Abstract
Background
Peripheral blood monocytes are important immune modulatory cells that change during aging. Previous studies on sepsis and monocytes did not distinguish between age groups, especially in the older adult population. The mechanisms of monocyte subsets and function are not well-understood in the aging context with sepsis.
Methods
Monocyte subsets were measured using flow cytometry in 80 sepsis patients and 40 healthy controls. Plasma cytokine levels were measured using cytokine antibody arrays.
Results
The percentage of MO3 (CD14 + CD16 + +)/monocytes was higher in sepsis patients than in controls (P = 0.011), whereas the percentage of MO1 (CD14 + + CD16 −)/monocytes was higher in septic shock patients and 28-day death group than in those without shock and 28-day survival group (P = 0.034, 0.038). Logistic regression analysis showed that the percentage of MO3/monocytes (OR = 1.120, P = 0.046) and plasma level of monocyte chemoattractant protein (MCP)-1 (OR = 1.006, P = 0.023) were independently associated with the occurrence of sepsis, whereas the percentage of MO1/monocytes (OR = 1.255, P = 0.048) was independently associated with septic shock. The receiver operating characteristic (ROC) curve showed that the area under the curve (AUC) of MO3/monocyte percentage in combination with MCP-1 plasma level (AUC = 0.799) for predicting sepsis was higher than that of each parameter alone (P < 0.001). The AUC of MO1/monocyte percentage with the value 0.706 (P = 0.003) was lower than the AUC of SOFA (sequential organ failure assessment) score with the value 0.966 (P < 0.001) for predicting septic shock, but the value of the two AUCs were similar for predicting 28-day mortality (AUC = 0.705, 0.827; P = 0.020, P < 0.001). The AUC of MO1/monocytes percentage in combination with SOFA score for predicting 28-day mortality was higher than that of each parameter alone (AUC = 0.867, P < 0.001). Using a cut-off of 58.5% (for MO1/monocytes determined by ROC) could discriminate between survivors and non-survivors on Kaplan–Meier curves for 28-day mortality with a positive predictive value of 77.4%.
Conclusion
The MO3/monocyte percentage and plasma MCP-1 level were independent predictors of sepsis occurrence, whereas the percentage of MO1/monocytes was an independent predictor of prognosis in the Chinese Han older adult population.
Trial registration
Registration number: ChiCTR2200061490, date of registration: 2022–6-26 (retrospectively registered).
Background
Sepsis is a severe infection with a series organ dysfunction that involved a complicated progress between pro- and anti-inflammatory course. Peripheral blood monocytes are critical immune cells that play important roles in immune responses. Human monocytes show different functional based on CD14 (lipopolysaccharide receptor) and CD16 (FcγIII receptor) expression on their cell surface [1, 2]. According to the expression of this two receptors, monocytes can be classified into “classical monocytes” with strong expression of CD14 and negative expression of CD16 (CD14 + + CD16 −), “intermediate monocytes” with both expression CD14 and CD16 (CD14 + + CD16 +), and “nonclassical monocytes” with mainly expressing CD16 (CD14 + CD16 + +) [1].
Aging causes changes in the immune system and represents a critical healthcare concern. It is characterized chronic low-grade inflammation in the older adult population including increased cell senescence and altered circulating level of cytokines [3, 4]. Monocytes are dynamic immune modulatory cells changing with aging. Previous studies on sepsis and monocytes did not distinguish age context mostly, especially in the older adult population. The mechanisms regulating monocyte phenotype and function are not well-understood in the aging context. Therefore, we investigated the association of different peripheral blood monocyte subsets and their secreted cytokines on the occurrence and development of sepsis in the older adult Chinese Han population.
Methods
Patients and control subjects
The participants were patients from two hospitals who were admitted to the emergency department (ED). The patients included were diagnosed with sepsis defined by the 2016 International Diagnostic Criteria for Sepsis 3.0 as life-threatening organ dysfunction caused by a dysregulated host response to infection and satisfied the age above 65. For clinical operationalization, organ dysfunction is indicated by an increase in the Sequential Organ Failure Assessment (SOFA) score by ≥ 2 points. Patients with septic shock are clinically identified by a vasopressor requirement to maintain a mean arterial pressure of ≥ 65 mmHg and plasma lactate level of > 2 mmol/L in the absence of hypovolemia [5]. The exclusion criteria were: (a) congenital and/or acquired immunodeficiency diseases, (b) long-term use of corticosteroids or immunosuppressive drugs, (c) patients with HIV infection or cancer, (d) death within 2 days of the onset of sepsis, signs of sepsis occurring more than 3 days prior to admission, (e) declined to participate. Blood samples were collected within 24 h after the sepsis criteria were met. A healthy control group was also from the two hospitals who were admitted to the physical examination centres. Subjects were excluded if they had hypertension, diabetes, coronary heart disease, or other serious diseases of the brain, lung, liver, or kidney. Blood samples were collected on the same day as admission to the physical examination centre.
Data collection
The clinical characteristics of patients, including age, sex, and laboratory examination results, were recorded after the onset of sepsis. The SOFA score and SAPS II score (simplified acute physiology score) were calculated based on related clinical and demographic data. The following outcome of survival condition (survival or death) was collected after 28 days during follow-up.
Flow cytometry
Peripheral whole blood was collected into ethylenediaminetetraacetic acid (EDTA) anticoagulant tubes. The antibodies were purchased from BD Biosciences (San Jose, CA, USA). Erythrocytes were lysed and stained by a technician who was blinded to the study. Cells were stained in the dark on ice for 30 min and washed twice. At least 10,000 monocytes were acquired using a BD FACS Aria II flow cytometer (BD Biosciences). Peripheral whole-blood cell analysis was performed using antibodies specific for human CD45 (clone HI30), CD14 (clone M5E2), and CD16 (clone 3G8). All antibodies were previously titred and optimized, depending on the fluorophore used. Forward scatter and side scatter and CD14 and CD16 positive signals based on isotype-matched control staining were used to gate monocytes. The forward scatter area vs. forward scatter height was used to gate single cells. The analysis was performed using FlowJo software (v. 10.0.8; Tree Star, Ashland, OR, USA). The results were expressed as percentages.
Cytokine testing
Peripheral venous blood samples were collected in tubes containing potassium EDTA and immediately centrifuged at 3000 × g for 10 min at ambient temperature. Plasma from the supernatant was extracted and frozen at − 80 °C until analysis. Cytokines were tested using cytokine antibody arrays (Quantibody® Human Inflammation Array 1) containing 10 human cytokines (interferon [IFN]-γ, interleukin [IL]-1α, IL-1β, IL-4, IL-6, IL-8, IL-10, IL-13, monocyte chemoattractant protein-1 [MCP-1], and tumour necrosis factor [TNF]-α). The fluorescence signal values were used for semiquantitative evaluation.
Statistical analysis
Normally and non-normally distributed data were described as mean ± standard deviation and median (interquartile range) respectively. Independent sample t-tests, Mann–Whitney U-tests and chi-square tests were used to compared the differences between groups as appropriate. Binary logistic regression was used to identify variables associated with the occurrence of sepsis, septic shock and 28-day mortality. The area under the curve (AUC) of receiver operating characteristic (ROC) curves was used to compare the prediction of sepsis occurrence, septic shock, and 28-day mortality in sepsis. Using cut-off values determined by ROC curves, comparisons of survival distributions were assessed by the log-rank test from Kaplan–Meier survival curves. All statistical tests were two-tailed, and statistical significance was set at P < 0.05. All data were analysed using SPSS 23.0 software.
Results
Patient characteristics
A total of 80 older adults Chinese Han sepsis patients and 40 healthy controls matched for sex, age, and race were included in this study (Fig. 1). The patients were divided into septic shock group (28) and septic group (patients without shock) (52) according to disease severity, death group (13) and survival group (67) according to the 28-day mortality. The demographic and clinical characteristics of patients are presented in Table 1. Septic shock group had higher SOFA and SAPS II scores than septic group. Patients in the septic shock group had higher 28-day mortality than those without shock group. Other parameters such as PCT, CRP and ESR shown no significant difference between the groups.
Monocyte subsets between patients and controls
We defined CD14 + + CD16 − (classical) monocyte as MO1 monocyte, CD14 + + CD16 + (intermediate) monocyte as MO2 monocyte, CD14 + CD16 + + (non-classical) monocyte as MO3 monocyte. Comparisons among the groups of percentage of monocyte subsets were illustrated in Fig. 2. The percentage of MO3 monocytes was higher in patients than in controls [3.1% (1.7%, 5.7%) vs. 1.9% (0.9%, 4.4%), P = 0.011] (Fig. 2c), whereas percentages of MO1 monocytes and MO2 monocytes shown no differences between patients and controls [56.4% (28.0%, 75.1%) vs. 56.9% (12.3%, 86.0%), P = 0.602; 14.5% (6.3%, 36.8%) vs. 15.5 (3.7%, 48.5%), P = 0.597, respectively] (Fig. 2a, b). Further analysis revealed a high percentage of MO1 monocytes in septic shock patients and 28-day death group than in those without shock group and 28-day survival group[68.8% (50.7%, 77.8%) vs. 40.8% (19.7%, 70.7%), P = 0.034; 54.3% (22.2%, 74.7%) vs. 70.9% (49.4%, 76.9%), P = 0.038] (Fig. 2a), no differences were observed on percentage of MO2 monocytes and MO3 monocytes between these groups [12.4% (8.9%, 34.2%) vs. 14.8% (6.8%, 41.6%), P = 0.988; 3.1% (2.0%, 4.9%) vs. 3.0% (1.7%, 5.9%), P = 0.992, respectively] (Fig. 2b, c). The percentages of MO2 and MO3 monocyte showed no significant differences between survival and death group according to 28-day mortality [14.2% (6.3%, 38.2%) vs. 15.2% (6.1%, 23.7%), P = 0.588; 3.2% (1.79%, 5.43%) vs. 2.7% (1.4%, 5.9%), P = 0.616, respectively] (Fig. 2b, c).
Differences in cytokines secreted by monocytes between patients and controls
Monocytes mainly secrete IL-6, IL-8, IL-10, MCP-1, TNF-α, and IL-1β [6]. In addition, we selected other important inflammatory cytokines, such as IL-1α, IL-4, IL-13, and IFN-γ, for detection. We found that the plasma levels of IL-6 (Fig. 3a), IL-8 (Fig. 3b), IL-10 (Fig. 3c), and MCP-1 (Fig. 3d) were upregulated in all patients (all P value < 0.001), the septic group (all P value < 0.001), and the septic shock group (all P value < 0.001) compared with those in control groups. However, no differences were observed between patients with septic shock and those without shock. Plasma levels of IL-6, IL-8, IL-10, and MCP-1 were also upregulated in non-survivors compared with those in survivors according to the 28-day mortality (all P value < 0.001). The other cytokines mentioned above were not significantly different among these groups, although slight differences were observed.
MO3 monocyte percentage and MCP-1 level as independent predictors of the occurrence of sepsis disease
In the subsequent multivariate logistic regression analysis, we found that MO3/monocytes (β = 1.113, OR = 1.120, CI: 1.002, 1.251, P = 0.046) and the MCP-1 plasma level (β = 0.006, OR = 1.006, CI: 1.001, 1.010, P = 0.023) were independently associated with the occurrence of sepsis disease (Table 2). The ROC curve showed that the AUCs of the MO3/monocyte percentage and MCP-1 plasma level for predicting sepsis were 0.745 and 0.765 (P < 0.001, P < 0.001), respectively. Moreover, the AUC of 0.799 (P < 0.001) for the percentage of MO3/monocytes in combination with the plasma level of MCP-1 for predicting sepsis was significantly higher than that for each parameter alone. The detailed data are presented in Table 3 and Fig. 4.
Percentage of MO1 monocytes as a new independent predictor of sepsis severity and prognosis
The MO1/monocyte percentage (β = 0.227, OR = 1.255, CI: 1.002, 1.572, P = 0.048) and SOFA score (β = 1.951, OR = 7.036, CI: 1.529, 32.383, P = 0.012) were independently associated with septic shock according to the disease severity using logistic regression analysis (Table 4). The ROC curve showed that the AUC of the percentage of MO1/monocytes was 0.705 (P = 0.003), but was lower than that of the SOFA score and SASP II for predicting septic shock in all patients (AUC = 0.966, 0.737; P < 0.001, = 0.001 respectively). Interestingly, the AUC of the percentage of MO1/monocytes was similar to that of the SOFA score for predicting 28-day mortality in all patients (Table 5), and the prognostic value of MO1/monocytes in combination with the SOFA score for predicting 28-day mortality was significantly higher than that for each parameter alone (Table 5 and Fig. 5).
Value of MO1/monocytes for predicting 28-day mortality in all sepsis patients
We further explored the significance of parameters in predicting 28-day mortality in all patients. The ROC curve showed that 58.5% was the optimal threshold in MO1/monocyte for predicting 28-day mortality in patients. The sensitivity, specificity, positive predictive value, and negative predictive value were 84.6%, 50.7%, 77.4%, and 62.2%, respectively. Using cut-off values determined by ROC curves, sepsis patients with a percentage of MO1/monocytes > 58.5% had a lower probability of survival on day 28 than patients with lower MO1/monocyte percentages (Fig. 6).
Discussion
Aging is associated with impaired immune function that leads to older adult becoming less responsive to myriad pathogen and more susceptible to a series of infections ultimately. Changes in cellular phenotypes and functions in immune cells with aging have been found. Our study demonstrated that the percentage of MO3 monocytes (CD14 + CD16 + +) was higher in all Chinese Han older adult sepsis patients than in controls. This is consistent with previous report that the proportion of monocyte subsets appears to an expansion of non‐classical (CD14 + CD16 + +) monocytes in older adult populations [7]. The CD14 + CD16 + + monocytes are also inflammatory cells owing to their potent pro-inflammatory activity [8]. In vitro, CD14 + CD16 + + monocytes produce higher amounts of the pro-inflammatory factor TNF-α and lower amounts of the anti-inflammatory cytokine IL-10 in response to Toll-like receptor stimulation [9, 10]. In vivo, the CD14 + CD16 + + monocyte population expands during infections, especially in sepsis [11]. All in vitro and in vivo studies have verified the clinical significance of CD14 + CD16 + + monocytes during inflammation. However, CD14 + CD16 + + monocytes also have a reduced phagocytic capacity by expressing lower levels of CCR2 (a chemokine receptor mediating monocyte chemotaxis during inflammation), and higher levels of CX3CR1 (a chemokine receptor mediating resident monocyte accumulation) [12], which implies that CD14 + CD16 + + monocytes also have an anti-inflammatory function by reducing phagocytic capacity [12]. This confusion regarding the characterization of human monocyte subsets may be due to the different immune statuses in various age groups. Aging increases the proportion of CD14 + CD16 + + monocytes in the circulation [13]. Studies on aging and monocytes have also shown that CD14 + CD16 + + monocytes exhibit various features of cellular senescence [14], and senescent cells accumulate with aging [15]. These cells typically undergo extensive changes in protein expression and secretion, resulting in the persistent secretion of pro-inflammatory cytokines [16]. The CD14 + CD16 + + monocytes also display reduced mitochondrial function in aging populations, which may enhance their reliance on pro-inflammatory glycolysis for ATP production [17], indicating a potential association between aging and changes in monocyte subset proportions and function. Our finding of the increased MO3 (CD14 + CD16 + +)/monocyte percentage in older adult Chinese Han sepsis verified the role of CD14 + CD16 + + monocytes in the occurrence of this disease.
Classical monocytes (CD14 + + CD16 −) are prominent monocytes in healthy individuals [18]. Substantially more evidence supports that CD14 + + CD16 − monocytes are pro-inflammatory cells due to their high abilities of secreting pro-inflammatory cytokines in response to microbial products [6]. In a neonatal population, sepsis patients exhibited a significant increase in CD14 + + CD16 − monocytes compared with controls, and CD14 + + CD16 − monocytes demonstrated better diagnostic and prognostic abilities in ROC analysis [19]. One research about Gram-negative sepsis show that the absolute counts of CD14 + + CD16 − monocytes on day 1 are higher in survivors compared than in non-survivors [20]. However, our study demonstrated that the percentage of MO1/monocytes (CD14 + + CD16 −) in survival group was lower than death group according to the 28-day mortality. Moreover, CD14 + + CD16 − monocytes were associated with a worse disease severity and prognosis in a subsequent analysis. This contradicting finding with the previous study may be explained by aging. Because research show that the proportion of monocyte subsets appears reducing in classical monocyte (CD14 + CD16 −) in elderly individuals [7]. Monocytes from older adults exhibit increased cytokine production compared with those from younger adults [21]. Transcriptomic profiling studies suggest that the proliferative capacity of CD14 + + CD16 − monocytes may decline with age [22], and the proportion of CD14 + + CD16 − monocytes in older adults is reduced compared with that in younger adults [13]. A recent review described that glycolysis contributes to increased inflammation, while slower fatty acid oxidation contribute to anti-inflammatory activities [23]. Fatty acid oxidation occurs in the mitochondria and aging impairs mitochondrial respiration in CD14 + + CD16 − monocytes [13]. Thus, mitochondrial dysfunction could suppress anti-inflammatory cellular activities, enhancing inflammation. Hence, the increasing MO1/monocyte (CD14 + + CD16 −) percentage in septic shock and 28-day survival patients in our study revealed early excessive inflammatory response in older adult patients with sepsis is an important underlying factor contributing to its severity and poor prognosis.
Human aging is associated with changes in the inflammatory cytokines IL-8 and MCP-1 synthesized by monocytes [24]. The release of a platelet granule protein causes the translocation of NF-κb into the nucleus of monocytes and triggers the synthesis of IL-8 and MCP-1 in older adult [25]. Increased levels of IL-6, IL-8, and MCP-1 during aging may contribute to adverse outcomes in older adult [26,27,28]. Our findings of upregulated IL-6, IL-8, and MCP-1 plasma levels according to 28-day mortality reconfirmed the previous results that excess inflammatory cytokines indicate poor prognosis. When monocytes are inactivated, they show a reduced ability to release pro-inflammatory cytokines, such as TNF-α, IL-1β, IL-6, and IL-12, and an increased capacity to secrete anti-inflammatory mediators, such as IL-10, as the disease progresses [29]. Our research showed that plasma IL-10 levels were significantly increased in all patients with sepsis, especially in the septic shock and 28-day mortality groups. This may indicate that an imbalance in cytokine release at the beginning of sepsis is a true state in older adult patients with sepsis. Among the four differentially expressed cytokines, the plasma MCP-1 level showed superior predictive value for the occurrence of sepsis, both alone and in combination with monocyte subtypes. This is consistent with the previous results that increased MCP-1 levels are associated with the highest mortality at 30 days and 6 months compared with lower levels in sepsis patients [30]. Classical monocytes secrete high levels of IL-8, IL-10, and MCP-1 in vitro [6]. Monocytes from older adult people secrete more IL-8 and MCP-1 than those from younger people in the presence of autologous platelets [24], indicating that the ability of monocytes to synthesize cytokines is altered with aging and disease.
The immune status of people of different ages is different and can be reflected by the changes in the proportion of peripheral blood monocyte subsets and their ability to secrete cytokines. The peripheral blood monocyte subsets combined with their cytokine expression provide a new predictor for early diagnosis, disease severity and prognosis in the older adult Chinese Han sepsis population.
Limitations
Our study had several limitations. First, the results cannot fully reflect the real true nature due to the limited number of samples in this study. Therefore, the sample size should be enlarged in future research. Second, our study focused on monocyte subsets and cytokine secretion at the beginning of sepsis, but these states may change along with the course of sepsis. Therefore, dynamic analysis in monocyte subsets and cytokine secretion in different stages of sepsis require further research.
Conclusions
This is the first study on the association of monocyte subsets and cytokine secretion with the occurrence and prognosis of sepsis in the older adult Chinese Han population aged > 65 years. Population aging is becoming increasingly serious worldwide, older adult sepsis is increasing. Therefore, it is particularly important to find new and effective indicators for early diagnosis and judgment of severity of sepsis. The conclusions of this study provide a basis for further studies on the immune status of older adult sepsis.
Availability of data and materials
The data that support the findings of this study are available from ResMan (http://www.medresman.org.cn/login.aspx) but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of ResMan.
Abbreviations
- ROC:
-
Receiver operating characteristic
- AUC:
-
Under the curve
- SOFA:
-
Sequential organ failure assessment
- ED:
-
Emergency department
- EDTA:
-
Ethylenediaminetetraacetic acid
- IFN:
-
Interferon
- MCP:
-
Monocyte chemoattractant protein
- TNF:
-
Tumor necrosis factor
- SASP II:
-
Simplified acute physiology II
References
Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010;116(16):e74-80.
Lund H, Boysen P, Akesson CP, Lewandowska-Sabat AM, Storset AK. Transient Migration of Large Numbers of CD14(++) CD16(+) Monocytes to the Draining Lymph Node after Onset of Inflammation. Front Immunol. 2016;7:322.
Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244–54.
Keenan CR, Allan RS. Epigenomic drivers of immune dysfunction in aging. Aging Cell. 2019;18(1):e12878.
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–10.
Cros J, Cagnard N, Woollard K, Patey N, Zhang SY, Senechal B, et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity. 2010;33(3):375–86.
Seidler S, Zimmermann HW, Bartneck M, Trautwein C, Tacke F. Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults. BMC Immunol. 2010;11:30.
Stansfield BK, Ingram DA. Clinical significance of monocyte heterogeneity. Clin Transl Med. 2015;4:5.
Belge KU, Dayyani F, Horelt A, Siedlar M, Frankenberger M, Frankenberger B, et al. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol. 2002;168(7):3536–42.
Mukherjee R, Kanti Barman P, Kumar Thatoi P, Tripathy R, Kumar Das B, Ravindran B. Non-Classical monocytes display inflammatory features: Validation in Sepsis and Systemic Lupus Erythematous. Sci Rep. 2015;5:13886.
Yang J, Zhang L, Yu C, Yang XF, Wang H. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark Res. 2014;2(1):1.
Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19(1):71–82.
Pence BD, Yarbro JR. Aging impairs mitochondrial respiratory capacity in classical monocytes. Exp Gerontol. 2018;108:112–7.
Ong SM, Hadadi E, Dang TM, Yeap WH, Tan CT, Ng TP, et al. The pro-inflammatory phenotype of the human non-classical monocyte subset is attributed to senescence. Cell Death Dis. 2018;9(3):266.
Herbig U, Ferreira M, Condel L, Carey D, Sedivy JM. Cellular senescence in aging primates. Science. 2006;311(5765):1257.
Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010;5:99–118.
Saare M, Tserel L, Haljasmagi L, Taalberg E, Peet N, Eimre M, et al. Monocytes present age-related changes in phospholipid concentration and decreased energy metabolism. Aging Cell. 2020;19(4):e13127.
Calderon TM, Williams DW, Lopez L, Eugenin EA, Cheney L, Gaskill PJ, et al. Dopamine Increases CD14(+)CD16(+) Monocyte Transmigration across the Blood Brain Barrier: Implications for Substance Abuse and HIV Neuropathogenesis. J Neuroimmune Pharmacol. 2017;12(2):353–70.
Hashem HE, Ibrahim ZH, Ahmed WO. Diagnostic, Prognostic, Predictive, and Monitoring Role of Neutrophil CD11b and Monocyte CD14 in Neonatal Sepsis. Dis Markers. 2021;2021:4537760.
Gainaru G, Papadopoulos A, Tsangaris I, Lada M, Giamarellos-Bourboulis EJ, Pistiki A. Increases in inflammatory and CD14(dim)/CD16(pos)/CD45(pos) patrolling monocytes in sepsis: correlation with final outcome. Crit Care. 2018;22(1):56.
Hearps AC, Martin GE, Angelovich TA, Cheng WJ, Maisa A, Landay AL, et al. Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging Cell. 2012;11(5):867–75.
Wong KL, Tai JJ, Wong WC, Han H, Sem X, Yeap WH, et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood. 2011;118(5):e16-31.
O’Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16(9):553–65.
Campbell RA, Franks Z, Bhatnagar A, Rowley JW, Manne BK, Supiano MA, et al. Granzyme A in Human Platelets Regulates the Synthesis of Proinflammatory Cytokines by Monocytes in Aging. J Immunol. 2018;200(1):295–304.
Weyrich AS, Elstad MR, McEver RP, McIntyre TM, Moore KL, Morrissey JH, et al. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest. 1996;97(6):1525–34.
Donato AJ, Black AD, Jablonski KL, Gano LB, Seals DR. Aging is associated with greater nuclear NF kappa B, reduced I kappa B alpha, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans. Aging Cell. 2008;7(6):805–12.
Pararasa C, Ikwuobe J, Shigdar S, Boukouvalas A, Nabney IT, Brown JE, et al. Age-associated changes in long-chain fatty acid profile during healthy aging promote pro-inflammatory monocyte polarization via PPARgamma. Aging Cell. 2016;15(1):128–39.
Rondina MT, Carlisle M, Fraughton T, Brown SM, Miller RR 3rd, Harris ES, et al. Platelet-monocyte aggregate formation and mortality risk in older patients with severe sepsis and septic shock. J Gerontol A Biol Sci Med Sci. 2015;70(2):225–31.
He J, Chen Y, Lin Y, Zhang W, Cai Y, Chen F, et al. Association study of MCP-1 promoter polymorphisms with the susceptibility and progression of sepsis. PLoS ONE. 2017;12(5):e0176781.
Barre M, Behnes M, Hamed S, Pauly D, Lepiorz D, Lang S, et al. Revisiting the prognostic value of monocyte chemotactic protein 1 and interleukin-6 in the sepsis-3 era. J Crit Care. 2018;43:21–8.
Acknowledgements
We thank Melissa Crawford, PhD, from Liwen Bianji (Edanz) (www.liwenbianji.cn/), for editing the English text of a draft of this manuscript.
Funding
Open Foundation from Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Grant/Award Number: 2018XFN‐KFKT‐02.
Author information
Authors and Affiliations
Contributions
QG and SG designed the study. QG and LY acquired the data. QG performed the analysis and interpretation of data. QG wrote the manuscript. SG and FT revised the manuscript. The author(s) read and approved the final manuscript.
Authors’ information
Not applicable.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
This study was conducted in compliance with the Declaration of Helsinki and approved by the institutional ethics committees of Beijing Chaoyang Hospital Affiliated to Capital Medical University and Beijing Shijitan Hospital Affiliated to Capital Medical University. All participants provided written informed consent. All participants provided written informed consent aforehand by themselves or their direct relative (When these older adult patients with sepsis are unable to sign the informed consent by themselves due to their illness such as neurological symptoms, we contact their immediate family members to obtain their consent and sign the informed consent).
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Gao, Q., Yang, L., Teng, F. et al. Peripheral blood monocyte status is a predictor for judging occurrence and development on sepsis in older adult population: a case control study. BMC Emerg Med 23, 11 (2023). https://0-doi-org.brum.beds.ac.uk/10.1186/s12873-023-00779-w
Received:
Accepted:
Published:
DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12873-023-00779-w